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Invasive trichosporonosis is a rare fungal infection, but
this disease has recently increasingly been recognized in
patients with hematological disorders. However, little is
known about the clinical characteristics of this infectious
complication. We evaluated consecutive trichosporon sep-
ticemia in 20 patients with hematological disorders at the
Mie University Hospital and related hospitals for 5 years
between January 2003 and December 2007. All patients
were male and age ranged 23—85 years (mean, 60.3).
Underlining diseases are acute myelogenous leukemia (AML)
in 18, macroglobulinemia in one and aplastic anemia in
one. All had a neutrophil count < 500 /l before the diag-
nosis of septicemia. Seventeen patients developed the
sepsis after intensive chemotherapies, one during steroid
treatment and two during observation. No patients exam-
ined had positive surveillance cultures for trichosporon.
Nineteen patients showed breakthrough septicemia during
the use of anti-fungal agents such as micafungin (MCFG)
in 17, ﬂuconazole (FLCZ) in 5, itraconazole in one and
amphotericin-B (AMPH-B) in 3. Only 4 patients, who had an
increase of neutrophil > 500 /l, recovered from this infec-
tion. Among them, two were treated with AMPH-B, FLCZ
and miconazole, one with AMPH-B and FLCZ, and one with
voriconazole only. We should pay attention to an occurrence
of breakthrough trichosporonemia when we use MCFG as an
empirical anti-fungal therapy for male patients with hema-
tological disorders and neutropenia. We need to develop an
effective strategy to treat this fungal infection because of
rapid onset and high mortality.
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Fungal rhinosinusitis is an increasingly important clini-
cal entity with a world-wide distribution. However, there is
paucity of information on its occurrence in Delhi and many
other parts of India.
Aim: The study aimed at probing the occurrence and fun-
gal etiology of rhino-sinusitis in Delhi area.
Methods: The study group comprised 50 patients with
chronic rhinosinusitis (CRS) examined in the ENT Depart-
ment, Lady Hardinge Medical College, New Delhi, during
July 2006 to September 2007. Endoscopically removed sinus
mucosa obtained from patients were investigated for fun-
gal etiology in the Medical Mycology, V. P. Chest Institute,
Delhi, by direct microscopy and fungal culture. One half of
each specimen was ﬁxed in formal saline for histopathologic
examination and the other half processed for mycologi-
cal investigations. Based on histopathologic observations,
the specimens were categorized as follows: Group I com-
prised specimens showing presence of mucin inﬁltrated with
hyphae suggestive of allergic fungal sinusitis (AFRS); Group
II had fungal hyphae without mucin suggestive of fungal ball;
Group III had mucin negative for fungal elements suggestive
of eosinophilic mucin rhinosinusitis, and Group IV showing
neither hyphae nor mucin indicating non-mycotic etiology.
Results: Fifty cases of CRS investigated, 23 (46%) had
demonstrable fungal etiology. This included 13 cases (26%)
classiﬁed as AFRS and 10 (20%) as fungal ball. Eight of the
cases in AFRS group were conﬁrmed by isolation of fungus
in culture. Aspergillus ﬂavus was the etiologic agent in 7 of
these cases whereas it was A. fumigatus in a solitary case. In
the fungal ball group, 7 cases were diagnosed by demonstra-
tion of fungus in histopathologic examination and 3 by direct
microscopy of KOH mounts. Only 5 of the fungal ball cases
were culture positive, the etiologic agent being A. ﬂavus in
4 cases and an unidentiﬁed Aspergillus in a solitary case.
Conclusion: Aspergillus ﬂavus is the predominant etio-
logic agent of fungal rhino-sinusitis in the Union Territory of
Delhi. We believe that the disease is being under-diagnosed
and under-reported in many parts of India due to inadequate
awareness or lack of mycological diagnostic facilities.
doi:10.1016/j.ijid.2008.05.745
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Background: The expanding population of HIV/AIDS has
led to an increase in individuals at risk of contracting oppor-
tunistic fungal infection particularly Candidiasis. Studies
have shown that there is a correlation between genotype
and antifungal susceptibility in Candida albicans. While ﬂu-
conazole resistance and unusual genotypic group of Candida
albicans has been reported elsewhere, no genotypic studies
have been conducted in Kenya.
Methods: We genotyped 92 Candida isolates from clinical
sources and determined ﬂuconazole susceptibility using pro-
cedures described in Clinical Laboratory Standard Institute
(CLSI) M27-A2 document. The isolates were recovered from
swabs (wound, mouth, HVS), urine, blood, aspirates and spu-
tum specimens in opportunistic infection study in Nairobi,
Kenya in 2006. Genotypic analyses were done with primers
